ReviewFrontiers in pharmacology2018

Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies.

Ian F Caplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.